Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Jessica Cardenas to Risk Factors

This is a "connection" page, showing publications Jessica Cardenas has written about Risk Factors.

 
Connection Strength
 
 
 
0.262
 
  1. Cotton BA, Cardenas JC. Targeting Chemoprophylaxis in Venous Thromboembolism Using Biomarker Guidance-Reply. JAMA Surg. 2023 02 01; 158(2):221-222.
    View in: PubMed
    Score: 0.071
  2. Rahbar E, Cotton BA, Wade CE, Cardenas JC. Acquired antithrombin deficiency is a risk factor for venous thromboembolism after major trauma. Thromb Res. 2021 08; 204:9-12.
    View in: PubMed
    Score: 0.063
  3. Cardenas JC, Holcomb JB. Time to plasma transfusion: a patient centered approach and modifiable risk factor. Transfusion. 2017 04; 57(4):869-873.
    View in: PubMed
    Score: 0.047
  4. Boya MN, Cieri IF, Rodriguez Alvarez AA, Patel S, Tinlin D, Cardenas J, Dua A. The Use of Thrombin Generation as a Predictor of Thrombosis in Peripheral Artery Disease. Ann Vasc Surg. 2025 Dec; 121:81-89.
    View in: PubMed
    Score: 0.021
  5. Watson C, Saaid H, Vedula V, Cardenas JC, Henke PK, Nicoud F, Xu XY, Hunt BJ, Manning KB. Venous Thromboembolism: Review of Clinical Challenges, Biology, Assessment, Treatment, and Modeling. Ann Biomed Eng. 2024 Mar; 52(3):467-486.
    View in: PubMed
    Score: 0.019
  6. Drake WP, Hsia C, Samavati L, Yu M, Cardenas J, Gianella FG, Boscardin J, Koth LL. Risk Indicators of Sarcoidosis Evolution-Unified Protocol (RISE-UP): protocol for a multi-centre, longitudinal, observational study to identify clinical features that are predictive of sarcoidosis progression. BMJ Open. 2023 04 03; 13(4):e071607.
    View in: PubMed
    Score: 0.018
  7. Myers SP, Brown JB, Leeper CM, Kutcher ME, Chen X, Wade CE, Holcomb JB, Schreiber MA, Cardenas JC, Rosengart MR, Neal MD. Early versus late venous thromboembolism: A secondary analysis of data from the PROPPR trial. Surgery. 2019 09; 166(3):416-422.
    View in: PubMed
    Score: 0.014
  8. Matijevic N, Wang YW, Wade CE, Holcomb JB, Cotton BA, Schreiber MA, Muskat P, Fox EE, Del Junco DJ, Cardenas JC, Rahbar MH, Cohen MJ. Cellular microparticle and thrombogram phenotypes in the Prospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study: correlation with coagulopathy. Thromb Res. 2014 Sep; 134(3):652-8.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)